Integra Lifesciences Holdings Corp (NAS:IART)
$ 24.8 -0.64 (-2.51%) Market Cap: 1.91 Bil Enterprise Value: 3.68 Bil PE Ratio: 0 PB Ratio: 1.26 GF Score: 71/100

Integra Lifesciences Holdings Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 13, 2021 / 05:15PM GMT
Release Date Price: $69.32 (-1.30%)
Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

Thank you for joining another med tech session here at the 2021 Morgan Stanley Healthcare Conference. I'm Drew Ranieri, one of the medical device analysts here. It's my pleasure to have Carrie Anderson, CFO, from Integra with us today as well as Mike, Head of IR. Just before we jump into it, time for some disclosures. But for important disclosures, please see morganstanley.com/researchdisclosures. And if you have any questions, please feel free to reach out to your Morgan Stanley sales rep.

So with that, Carrie, thank you so much for your time today. Really appreciate the opportunity to have a fireside chat with you. I don't think you're going to be surprised what our first topic will be.

Questions & Answers

Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

So maybe just give us an update of the business, the procedure impact that you might be seeing from the delta variants or any impact on the capital business to start with.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot